| HGNC Family | Zinc fingers |
| Name | MORC family CW-type zinc finger 2 |
| Description | This gene encodes a member of the Microrchidia (MORC) protein superfamily. The encoded protein is known to regulate the condensation of heterochromatin in response to DNA damage and play a role in repressing transcription. The protein has been found to regulate the activity of ATP citrate lyase via specific interaction with this enzyme in the cytosol of lipogenic breast cancer cells. The protein also plays a role in lipogenesis and adipocyte differentiation. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2016] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMORC2 encodes an ATPase-dependent chromatin remodeler that plays a pivotal role in the maintenance of genomic integrity. In response to DNA damage, MORC2 is post‐translationally modified – for example, phosphorylated by kinases such as p21‐activated kinase 1 and PARylated by PARP1 – which stimulates its ATPase activity to remodel chromatin and promote efficient recruitment of DNA repair factors. Furthermore, MORC2 forms homodimers and associates with the HUSH complex to enforce epigenetic silencing, thereby regulating transcription in a manner critical for genome stability."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn various human cancers, MORC2 functions as a potent oncogene by reprogramming transcription and metabolic pathways to favor tumor progression. Within the nucleus, it recruits chromatin modifiers such as SIRT1, EZH2, and interacts with factors that downregulate tumor suppressors (including p21, NDRG1, and ArgBP2) while promoting cell cycle progression, epithelial–mesenchymal transition, invasion, and metastasis. In the cytosol, MORC2 can interact with metabolic enzymes like ATP–citrate lyase (ACLY) and modulate glucose metabolism via the MYC/MAX axis, linking metabolic adaptation with aggressive cancer phenotypes. Its ability to regulate alternative splicing events further contributes to the metastatic behavior observed in cancers such as triple‐negative breast cancer, colorectal cancer, gastric cancer, liver cancer, cholangiocarcinoma, glioma, and lung cancer."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "26"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nPathogenic mutations in MORC2 have been linked to a diverse spectrum of neuropathies, including axonal Charcot–Marie–Tooth disease and related neurodevelopmental disorders. Such mutations disrupt MORC2’s normal dimerization, chromatin remodeling, and DNA repair activities, leading to aberrant gene regulation in neural cells and contributing to variable clinical phenotypes. Emerging therapeutic strategies, including gene therapy approaches, are beginning to address these loss‐of-function consequences, highlighting the clinical importance of MORC2 in neural as well as peripheral nerve biology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "27", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Da-Qiang Li, Sujit S Nair, Kazufumi Ohshiro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2012.11.018"}], "href": "https://doi.org/10.1016/j.celrep.2012.11.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23260667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23260667"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Hong-Yi Liu, Ying-Ying Liu, Fan Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkaa130"}], "href": "https://doi.org/10.1093/nar/gkaa130"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32112098"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32112098"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Lin Zhang, Da-Qiang Li "}, {"type": "b", "children": [{"type": "t", "text": "MORC2 regulates DNA damage response through a PARP1-dependent pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkz545"}], "href": "https://doi.org/10.1093/nar/gkz545"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31616951"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31616951"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Iva A Tchasovnikarova, Richard T Timms, Christopher H Douse, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.3878"}], "href": "https://doi.org/10.1038/ng.3878"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28581500"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28581500"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Christopher H Douse, Stuart Bloor, Yangci Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuropathic MORC2 mutations perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-03045-x"}], "href": "https://doi.org/10.1038/s41467-018-03045-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29440755"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29440755"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hong-Yan Xie, Tai-Mei Zhang, Shu-Yuan Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dimerization of MORC2 through its C-terminal coiled-coil domain enhances chromatin dynamics and promotes DNA repair."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Commun Signal (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12964-019-0477-5"}], "href": "https://doi.org/10.1186/s12964-019-0477-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31796101"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31796101"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Beatriz Sánchez-Solana, Da-Qiang Li, Rakesh Kumar "}, {"type": "b", "children": [{"type": "t", "text": "Cytosolic functions of MORC2 in lipogenesis and adipogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2013.11.012"}], "href": "https://doi.org/10.1016/j.bbamcr.2013.11.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24286864"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24286864"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Qing Zhang, Yanyan Song, Wei Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "By recruiting HDAC1, MORC2 suppresses p21 Waf1/Cip1 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.3889"}], "href": "https://doi.org/10.18632/oncotarget.3889"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26098774"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26098774"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Guiling Wang, Yanyan Song, Tong Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.3185"}], "href": "https://doi.org/10.18632/oncotarget.3185"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25888627"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25888627"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Fang-Lin Zhang, Jin-Ling Cao, Hong-Yan Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-17-1394"}], "href": "https://doi.org/10.1158/0008-5472.CAN-17-1394"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30093560"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30093560"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jiao Liu, Yangguang Shao, Yuxin He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.13863"}], "href": "https://doi.org/10.1111/cas.13863"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30407715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30407715"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Qian-Shan Ding, Li Zhang, Bi-Cheng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant high expression level of MORC2 is a common character in multiple cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2018.03.011"}], "href": "https://doi.org/10.1016/j.humpath.2018.03.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29555576"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29555576"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Gui-Ling Wang, Chun-Yu Wang, Xin-Ze Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and expression analysis of a novel CW-type zinc finger protein MORC2 in cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Anat Rec (Hoboken) (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ar.21119"}], "href": "https://doi.org/10.1002/ar.21119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20225202"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20225202"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Zhihong Pan, Qianshan Ding, Qian Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2018.4333"}], "href": "https://doi.org/10.3892/ijo.2018.4333"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29620211"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29620211"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yuxin Tong, Yan Li, Hui Gu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HSF1, in association with MORC2, downregulates ArgBP2 via the PRC2 family in gastric cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Basis Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbadis.2018.01.011"}], "href": "https://doi.org/10.1016/j.bbadis.2018.01.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29339121"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29339121"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yuxin Tong, Yan Li, Hui Gu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Microchidia protein 2, MORC2, downregulates the cytoskeleton adapter protein, ArgBP2, via histone methylation in gastric cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.10.059"}], "href": "https://doi.org/10.1016/j.bbrc.2015.10.059"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26476214"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26476214"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Guanqun Liao, Xiaopeng Liu, Dehai Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.102003"}], "href": "https://doi.org/10.18632/aging.102003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31180332"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31180332"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Meihan Liu, Xiaochun Sun, Shaomin Shi "}, {"type": "b", "children": [{"type": "t", "text": "MORC2 Enhances Tumor Growth by Promoting Angiogenesis and Tumor-Associated Macrophage Recruitment via Wnt/β-Catenin in Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000495673"}], "href": "https://doi.org/10.1159/000495673"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30504718"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30504718"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jia Liu, Qing Zhang, Banlai Ruan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MORC2 regulates C/EBPα-mediated cell differentiation via sumoylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Differ (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41418-018-0259-4"}], "href": "https://doi.org/10.1038/s41418-018-0259-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30644437"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30644437"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Rohith Kumar Guddeti, Liz Thomas, Anbarasu Kannan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The chromatin modifier MORC2 affects glucose metabolism by regulating the expression of lactate dehydrogenase A through a feed forward loop with c-Myc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1873-3468.14062"}], "href": "https://doi.org/10.1002/1873-3468.14062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33626175"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33626175"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Jing Zhang, Yunna Yang, Yipeng Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2021.5071"}], "href": "https://doi.org/10.3892/ijmm.2021.5071"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34913078"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34913078"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Rohith Kumar Guddeti, Himavani Pacharla, Nanda Kumar Yellapu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MORC2 and MAX contributes to the expression of glycolytic enzymes, breast cancer cell proliferation and migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-023-01974-2"}], "href": "https://doi.org/10.1007/s12032-023-01974-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36802305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36802305"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yuqin Tan, Tong Zheng, Zijun Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alternative polyadenylation reprogramming of MORC2 induced by NUDT21 loss promotes KIRC carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JCI Insight (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/jci.insight.162893"}], "href": "https://doi.org/10.1172/jci.insight.162893"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37737260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37737260"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Namita Chutani, Sandhya Ragula, Khajamohiddin Syed, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel Insights into the Role of Chromatin Remodeler MORC2 in Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomolecules (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/biom13101527"}], "href": "https://doi.org/10.3390/biom13101527"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37892209"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37892209"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Fan Yang, Rui Sun, Zeng Hou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HSP90 N-terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2-driven breast cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Transl Med (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ctm2.825"}], "href": "https://doi.org/10.1002/ctm2.825"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35522895"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35522895"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Yuxin He, Yangguang Shao, Zhihui Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MORC2 regulates RBM39-mediated CDK5RAP2 alternative splicing to promote EMT and metastasis in colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-024-06908-y"}], "href": "https://doi.org/10.1038/s41419-024-06908-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39048555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39048555"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Teresa Sevilla, Vincenzo Lupo, Dolores Martínez-Rubio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awv311"}], "href": "https://doi.org/10.1093/brain/awv311"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26497905"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26497905"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Maria J Guillen Sacoto, Iva A Tchasovnikarova, Erin Torti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "De Novo Variants in the ATPase Module of MORC2 Cause a Neurodevelopmental Disorder with Growth Retardation and Variable Craniofacial Dysmorphism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2020.06.013"}], "href": "https://doi.org/10.1016/j.ajhg.2020.06.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32693025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32693025"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Paula Sancho, Luca Bartesaghi, Olivia Miossec, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddz006"}], "href": "https://doi.org/10.1093/hmg/ddz006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30624633"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30624633"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Rafael Sivera, Vincenzo Lupo, Marina Frasquet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Charcot-Marie-Tooth disease due to MORC2 mutations in Spain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Neurol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/ene.15001"}], "href": "https://doi.org/10.1111/ene.15001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34189813"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34189813"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Dragan Vujovic, David R Cornblath, Steven S Scherer "}, {"type": "b", "children": [{"type": "t", "text": "A recurrent MORC2 mutation causes Charcot-Marie-Tooth disease type 2Z."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Peripher Nerv Syst (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jns.12443"}], "href": "https://doi.org/10.1111/jns.12443"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33844363"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33844363"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Hye Yoon Chung, Geon Seong Lee, Soo Hyun Nam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Morc2a variants cause hydroxyl radical-mediated neuropathy and are rescued by restoring GHKL ATPase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awae017"}], "href": "https://doi.org/10.1093/brain/awae017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38227798"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38227798"}]}]}]}
|
| Synonyms | ZCWCC1, ZCW3, CMT2Z |
| Proteins | MORC2_HUMAN |
| NCBI Gene ID | 22880 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MORC2 has 5,772 functional associations with biological entities spanning 9 categories (molecular profile, organism, disease, phenotype or trait, functional term, phrase or reference, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 113 datasets.
Click the + buttons to view associations for MORC2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MORC2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of MORC2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MORC2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of MORC2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of MORC2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MORC2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of MORC2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MORC2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MORC2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MORC2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of MORC2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MORC2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MORC2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MORC2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MORC2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MORC2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with MORC2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing MORC2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MORC2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing MORC2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing MORC2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing MORC2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MORC2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MORC2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with MORC2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MORC2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by MORC2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving MORC2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with MORC2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MORC2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MORC2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MORC2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with MORC2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MORC2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MORC2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MORC2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing MORC2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of MORC2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MORC2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MORC2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of MORC2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MORC2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of MORC2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MORC2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MORC2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of MORC2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving MORC2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MORC2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MORC2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing MORC2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing MORC2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing MORC2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by MORC2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by MORC2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by MORC2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of MORC2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MORC2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MORC2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with MORC2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of MORC2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of MORC2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of MORC2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of MORC2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MORC2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for MORC2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MORC2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by MORC2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for MORC2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MORC2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of MORC2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MORC2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate MORC2 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MORC2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of MORC2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with MORC2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MORC2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of MORC2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MORC2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting MORC2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MORC2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of MORC2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of MORC2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing MORC2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for MORC2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MORC2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of MORC2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving MORC2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MORC2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with MORC2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate MORC2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of MORC2 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2024 | pathways involving MORC2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MORC2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MORC2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MORC2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MORC2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MORC2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MORC2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MORC2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MORC2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with MORC2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of MORC2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of MORC2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of MORC2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of MORC2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of MORC2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of MORC2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of MORC2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MORC2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of MORC2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MORC2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MORC2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MORC2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |